ASKA and HCR have been working together for several years in Canada, North America and Europe. In 2008, both companies signed a non-exclusive strategic alliance agreement to expand the global reach of both companies, thereby optimising services to their clients in all aspects of global drug and medical device development, education services and clinical trial management... read more

Since 2009, HCR and Acrovan have established a non-exclusive teaming agreement. Acrovan is headquartered in Seoul, South Korea and has affiliate offices in China and USA. We look forward to a good cooperation with Acrovan, aimed at enlarging our capabilities in all the Asian markets, particularly Korea and China... read more

In 2009, HCR and the CoreMed Corporation signed a non-exclusive teaming agreement, in order to increase our efficiency in Japan, particularly in the areas of early stage development and product registration strategies in Japan... read more

HCR and Clinical Network Services (CNS), of Brisbane, Australia, signed a non-exclusive teaming agreement in 2010, after cooperating together with mutual partners for many years. Both companies value the close cooperation which allows their respective customers to work internationally in Australasia and/or Europe without having to use CROs with whom they have no prior relationship. In addition, both companies are interested to further explore the synergies that exist between Australia's fast start up environment in phase I and HCR's high recruiting phase I clinic in Munich. This will enable SME clients to move quickly into the clinic and thereafter into larger patient populations, reducing timelines significantly... read more